SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-030400
Filing Date
2017-05-05
Accepted
2017-05-05 17:29:54
Documents
2
Period of Report
2017-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2228
2 POA DOCUMENT poa.txt EX-24.3_721736 3359
  Complete submission text file 0001209191-17-030400.txt   7060
Mailing Address C/O KOS PHARMACEUTICALS INC 1001 BRICKELL AVE 25TH FL MIAMI FL 33131
Business Address
KING RICHARD (Reporting) CIK: 0001013702 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36399 | Film No.: 17819616

Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations